Given the role of SHP2 in the activation of the RAS/ERK pathway, we speculated that SHP2 inhibitors impede MM cell proliferation and cell-cycle progression by regulating the ERK signaling pathway. The gene discussed is PTPN11; the disease is Miyoshi myopathy.